Abstract Despite massive investments in the development of novel treatments for heterogeneous diseases such as COPD, the resources spent have only benefited a fraction of the population treated. Personalized health care to guide selection of a suitable patient population already in the clinical development of new compounds could offer a solution. This review discusses past […]
Clinical Drug Development Using Dynamic Biomarkers to Enable Personalized Health Care in COPD.
July 1, 2015
Chest